Sen. Kennedy rallies for the Medicare bill
Senate passage of H.R. 6331 was highlighted by Sen. Ted Kennedy's, D-Mass., dramatic appearance on the Senate floor. Kennedy, undergoing treatment for brain cancer, received a standing ovation upon entering the Senate July 9. Senate leaders cited his presence as a reason that some Senate Republicans added their support for the bill. The vote capped off a day when Senate Finance Committee Chairman Max Baucus, D-Mont., went all out to demonstrate widespread support for the bill, including holding briefings with veterans and military dependents
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”